Palvella Therapeutics Insider Trades

PVLA

Track insider trading activity from Palvella Therapeutics executives and directors. See which insiders are buying and selling PVLA stock.

Trades Last 12 Months

PVLA Price

All Insider Trades for Palvella Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Goin Kathleen Chief Operating Officer
Holding Value $630k 4,313 shares
Last Trade
Oct 21, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$546k 4,313 shares
$126.58
$146.15
Jenkins George M Director
Holding Value $20.4M 139,314 shares
Last Trade
Oct 14, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$886k 7,174 shares
$123.48
$146.15
Holding Value $36.5k 250 shares
Last Trade
Sep 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$49.1k 313 shares
$157.00
$146.15
Pauls Matthew Director
Holding Value $877k 6,000 shares
Last Trade
Jun 29, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$929k 6,000 shares
$154.84
$146.15
Korenberg Matthew E Cfo, Treasurer
Holding Value $146k 1,000 shares
Last Trade
Jun 12, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$109k 1,000 shares
$108.81
$146.15
Davis Todd C Director
Holding Value $438k 3,000 shares
Last Trade
Jun 10, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$307k 3,000 shares
$102.19
$146.15
Doux John Director
Holding Value $438k 3,000 shares
Last Trade
Jun 10, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$307k 3,000 shares
$102.19
$146.15
Heron Elaine J Director
Holding Value $438k 3,000 shares
Last Trade
Jun 10, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$307k 3,000 shares
$102.19
$146.15
Wessel Tadd S. Director
Holding Value $438k 3,000 shares
Last Trade
Jun 10, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$307k 3,000 shares
$102.19
$146.15
Jenkins George M Director
Holding Value $27.4M 187,616 shares
Last Trade
Mar 30, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$50k 445 shares
$112.30
$146.15
Heron Elaine J Director
Holding Value $6.99M 47,812 shares
Last Trade
Feb 27, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$300k 2,400 shares
$125.00
$146.15
Kaupinen Wes 10% owner, President And CEO
Holding Value $18.2M 124,603 shares
Last Trade
Feb 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.52M 124,603 shares
$76.43
$146.15
Martini Jeffrey S Chief Scientific Officer
Holding Value $9.4M 64,318 shares
Last Trade
Feb 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.92M 64,318 shares
$76.43
$146.15
Kline Ashley Hartmann Chief Commercial Officer
Holding Value $5.63M 38,517 shares
Last Trade
Feb 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.94M 38,517 shares
$76.43
$146.15
Holding Value $1.8M 12,350 shares
Last Trade
Jun 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$324k 12,350 shares
$26.23
$146.15
Palvella Therapeutics, Inc. Chief Scientific Officer
Holding Value $18.1M 123,559 shares
Last Trade
Feb 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$146.15

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up